AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2022
Oct 17, 2022
31565_dirs_2022-10-17_78eb4017-da0d-4418-9031-7ef77c8764b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2022-10-10
Reporting Person: Galvin Roy (President, Global Plasma & BC)
More from HAEMONETICS CORP
Annual Report
2026
Jun 9
Proxy Solicitation & Information Statement
2026
Jun 9
Proxy Solicitation & Information Statement
2026
Jun 9
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 28
Annual Report
2026
May 20
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30